HTL0039732 is a novel EP4 antagonist with potential to treat a wide range of cancers in combination with other immunotherapiesTOKYO,...
FDA clears Investigational New Drug (IND) application for lead gene therapy product candidate, FT-001, for the treatment of a rare...
– Scientific collaborators at Stanford University will present preclinical data on the sensitivity of OP-801 in comparison to TSPO-PET for...
MELBOURNE, Australia, July 14, 2022 /PRNewswire/ -- A Qualitative Research Study accomplished by Data Bridge Market research's database of 350...
MCRA's Regulatory Team was retained by NeuroMetrix to lead the strategy and development of a De Novo submission to the...
Quantitative biomarkers of demyelination can improve clinical trial design and accelerate development of disease-modifying therapeutics SAN FRANCISCO, July 14, 2022...
Differentiation amongst these pipeline agents will hinge on ease of access, easy-to-use companion diagnostics, and safety EXTON, Pa., July 14,...
North Boulder Chiropractic and Restoration Neurology Onboard EYE-SYNC technology to improve patient care with objective data Palo Alto, CA—October 7,...